Chile vs Ecuador: Reported rate of new cervical cancer cases
Chile
16.68 per 100,000 women
in 2017
Ecuador
17.16 per 100,000 women
in 2017
Chile rank
3rd
Ecuador rank
2nd
Reported rate of new cervical cancer cases over time
- Chile
- Ecuador
How they compare
Ecuador currently reports 17.16 per 100,000 women against 16.68 per 100,000 women in Chile, a difference of 0.48 per 100,000 women.
The two have swapped places 4 times across 20 shared years of data; in 1998 it was Ecuador ahead.
Chile ranks 3rd and Ecuador ranks 2nd of 46 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Ecuador in 2.
Head to head by decade
| Decade | Chile | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.15 per 100,000 women | 20.62 per 100,000 women | 1.53 per 100,000 women | Chile |
| 2000s | 17.54 per 100,000 women | 19.23 per 100,000 women | 1.68 per 100,000 women | Ecuador |
| 2010s | 12.75 per 100,000 women | 17.93 per 100,000 women | 5.18 per 100,000 women | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Chile or Ecuador?
- Ecuador, at 17.16 per 100,000 women against 16.68 per 100,000 women in Chile as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Chile and Ecuador?
- 0.48 per 100,000 women, with Ecuador ahead.
- How many years of comparable data are there for Chile and Ecuador?
- 20 years are reported by both, from 1998 to 2017.
- How do Chile and Ecuador rank globally for reported rate of new cervical cancer cases?
- Chile ranks 3rd and Ecuador ranks 2nd of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.